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Keratinocytes exposed to interferon (IFN)-g synthesize
major histocompatibility complex class II antigens both
in vivo and in vitro; however, the expression of class II
accessory genes has not yet been investigated. In this
study, we examined the capacity of normal human
keratinocytes activated with IFN-g to express HLA-DR,
HLA-DM, and invariant chain genes as well as two major
transcription regulatory genes, class II transactivator and
RFX5. Cultured keratinocytes were shown to synthesize
low levels of DMα, invariant chain p33, and RFX5
transcription factor. Upon treatment with IFN-g, expres-
sion of RFX5, DMa, and invariant chain p33 mRNA
increased, whereas class II transactivator mRNA appeared
de novo, followed by the expression of DRα, DMβ, and
Major histocompatibility complex (MHC) class IImolecules are heterodimeric cell surface glycopro-teins that present antigenic peptides to CD41 Tlymphocytes, and thus play a key role in the controlof the immune response. The molecular mechanisms
responsible for the maturation of MHC class II molecules after their
biosynthesis have been extensively studied (Pieters, 1997). The α and
β chains of the class II molecules assemble in a nonameric complex
together with the invariant chain (Ii). Ii is a nonpolymorphic protein
that exists as four related forms, p33, p35, p41, and p43, that arise
from a single gene by alternative splicing of one exon and the use of
two translation initiation sites (Strubin et al, 1986). Ii serves two major
functions: it directs the intracellular transport of MHC class II molecules
to the endocytic pathway, and it prevents the binding of peptides to
class II until the loading compartment is reached (Cresswell, 1996). In
the class II loading compartment, Ii is gradually processed to small
fragments, also known as class-II associated Ii peptide (CLIP), which
transiently remain in the class II binding groove and are then exchanged
for antigenic peptides. This final step requires an additional protein,
HLA-DM, which is a class II-like molecule that co-localizes with
HLA-DR in the compartment where class II peptide complexes form,
and it is not exported to the cell surface (Sanderson et al, 1994). HLA-
DM favors CLIP dissociation from class II and selects those antigenic
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invariant chain p41 genes. Western blot analysis showed
that both p33 and p41 invariant chain forms and DM
became detectable in keratinocytes after stimulation with
IFN-g, with a higher p41/p33 ratio compared with Raji
B cells. Finally, HLA-DR molecules present on IFN-
a-treated keratinocytes were shown to be remarkably
resistant to sodium dodecyl sulfate denaturation at room
temperature, a feature that class II molecules acquire
when their groove is properly loaded with peptide. These
results suggest that human keratinocytes activated with
IFN-g possess the biochemical requirements for the gen-
eration of functional class II peptide complexes. Key
words: antigen processing/epithelial cells/HLA-DM/invariant
chain/MHC class II. J Invest Dermatol 110:138–142, 1998
peptides forming more stable complexes with class II, thus directing
the final editing of class II peptide complexes (Kropshofer et al, 1997).
The effective binding of peptides to class II molecules is manifested
by the generation of α/β dimers that are stable upon incubation in high
concentrations of sodium dodecyl sulfate (SDS) at room temperature
(Sadegh-Nasseri and Germain, 1991). Recently, it has been demon-
strated that the constitutive and interferon (IFN)-γ-inducible expression
of MHC class II, Ii, and HLA-DM molecules are under the control
of two key transcriptional activators, a trans-acting factor, class II
transactivator (CIITA), and the DNA-binding protein of the RFX
family, RFX5 (Reith et al, 1995).
In normal human epidermis MHC class II molecules are expressed
only on Langerhans cells and not on keratinocytes (Mommaas et al,
1995); however, it has been amply documented that keratinocytes can
express class II in many skin disorders with prominent lymphocytic
infiltrate (Aubo¨ck et al, 1986). This phenomenon has been attributed
to IFN-γ released by infiltrating Th0 or Th1 cells, and can be
reproduced in vitro on cultured keratinocytes (Basham et al, 1984, 1985;
Wikner et al, 1986). The functional relevance of class II expression by
human keratinocytes has not been fully investigated yet. In this study
we demonstrate that cultured human keratinocytes activated with
IFN-γ express CIITA, RFX5, HLA-DR, HLA-DM, and Ii molecule
genes as well as HLA-DR, Ii, and HLA-DM proteins, and can generate
mature, SDS-resistant class II molecules.
MATERIALS AND METHODS
Antibodies Fluoroscein isothiocyanate (FITC)-conjugated anti-HLA-DR
monoclonal antibody (MoAb) (L243, IgG2a) and FITC-conjugated mouse
IgG2a were purchased from Becton-Dickinson (San Jose, CA). TAL.1B5 and
DK22 MoAb, which recognize the HLA-DR α chain and the β subunit of
HLA-DR, HLA-DP, and HLA-DQw1, respectively, were purchased from
Dako (Glostrup, Denmark). DA6.147 and HB10.A MoAb, directed against the
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HLA-DR α and β subunits (Mellins et al, 1990), respectively, were kindly
provided by Dr. E. Mellins (Children’s Hospital of Philadelphia, Philadelphia,
PA). Anti-COOH terminus of Ii MoAb LN2 was from Pharmingen (San
Diego, CA), whereas anti-NH2 terminus of Ii MoAb Pin.1 (Roche et al, 1991)
was a generous gift of Dr. P. Cresswell (Howard Hughes Medical Institute,
Section of Immunobiology, Yale University, New Haven, CT). The PS/JG
DMβ MoAb raised against the β-chain of HLA-DM (Green et al, 1995) was
graciously provided by Dr. S. K. Pierce (Department of Biochemistry, Molecular
Biology and Cell Biology, Northwestern University, Evanston, IL).
Cell cultures Samples of normal human skin were obtained from adult
donors undergoing abdominoplasty or mammoplasty surgery. Epidermal cell
suspensions were prepared as previously described (Girolomoni et al, 1993).
Briefly, epidermal sheets were separated from dermis using 0.5% dispase
(Boehringer, Mannheim, Germany), and then processed to single cell suspensions
using 0.25% trypsin (Biochrom, Berlin, Germany). Viable epidermal cells were
seeded (1.2–2 3 104 per cm2) on a feeder layer of irradiated 3T3/J2 fibroblasts
(2 3 104 per cm2), and cultured in a modified Green’s medium consisting of
a 3:1 mixture of Dulbecco’s modified Eagle’s medium and Ham’s F12 medium
(Biochrom) supplemented with 10% fetal bovine serum (Delta Bioproducts,
Johannesburg, South Africa), 180 µM adenine, 5 µg insulin per ml, 5 µg
apotransferrin per ml, 0.1 nM cholera toxin, 2 nM triiodotyronine, 10 ng
human epidermal growth factor per ml (all from Sigma, St. Louis, MO), 4 mM
glutamine, 100 U penicillin per ml, and 100 µg streptomycin per ml (Biochrom).
In selected experiments, keratinocytes were cultured in serum-free medium
(KGM; Clonetics, San Diego, CA). During incubation with IFN-γ, the bovine
pituitary extract and hydrocortisone were omitted from the medium. All
experiments were performed with second or third passage keratinocytes that
were devoid of contaminating leukocytes. Cell lines were purchased from the
American Type Culture Collection (Rockville, MD). The A431 keratinocyte-
like cell line was cultured in Dulbecco’s modified Eagle’s medium with 10%
fetal bovine serum added. The B lymphoma cell line Raji and the NCTC
epithelial-like cell line were grown in RPMI 1640 (Biochrom) supplemented
with 20% and 10% fetal bovine serum, respectively. Normal keratinocytes and
epithelial cell lines were treated with recombinant human IFN-γ (100–500 U
per ml; Genzyme, Cambridge, MA).
RNA isolation and analysis Total cellular RNA was extracted from
keratinocytes, A431, NCTC, Raji, and irradiated 3T3 with a modified guanidine
isothiocyanate-acid phenol protocol (Stallcup and Washington, 1983) using an
UltraspecTM RNA Isolation System (Houston, TX). For reverse transcriptase
polymerase chain reaction (RT-PCR) analysis, 1 µg of total RNA was reverse-
transcribed with oligo-dT as primers, using a Perkin-Elmer RNA PCR kit
(Roche Molecular Systems, Branchburg, NJ), following the manufacturer’s
instructions. Amplifications of cDNA were performed using standard techniques
(Wang et al, 1989) with a Perkin Elmer GeneAmp PCR System. The follow-
ing synthetic oligonucleotides were used: for DRα amplification,
primers CGAGTTCTATCTGAATCCTG and GTTCTGCTGCATTGCTTT-
TGC (650 bp of amplificate) (Chang et al, 1994); for DMα, primers
ACCTACTGTGTGGCAAGAAGGTATG and GCTGGCATCAAACTCTG-
GTCTGGAA (835 bp of amplificate); for DMβ, primers TCCTT-
CAACAAGGATCTGCTG and CTTCCTCCACGTGATAGTCAC (300 bp
of amplificate) (Kelly et al, 1991); for p41-Ii and p33-Ii, CAGAAC-
CTGCAGCTGGAGA-ACCTGCGCATG as 59 primer and GCAGTTA-
TGGTGCCCGCGGCTTCTGGTGTT or CAGTTCCAGTGACTCTTT-
CGGTGGAGCGTC as 39 primers, respectively (length of amplificates 560 bp
for p41-Ii and 384 bp for p31-Ii) (Strubin et al, 1984, 1986); for CIITA, primers
CAAGTCCCTGAAGGATGTGGA and ACGTCCATCACCCGGAG-
GGAC (370 bp of amplificate) (Steimle et al, 1993); for RFX5, primers
AAGCTGTATCTCTACCTTCAG and TTTCAGGATCCGCTCTGCCCA
(470 bp of amplificate) (Steimle et al, 1995). As an internal control for
the amount of RNA used, amplification of glutharaldehyde-3-phosphate
dehydrogenase (G3PDH) mRNA (expected cDNA product, 950 bp) was
included. To verify the absence of genomic DNA contamination in the RNA
samples, in some PCR reactions reverse transcriptase was omitted. For northern
blot experiments, RNA samples were electrophoresed on 1% agarose gels,
followed by northern blot transfer onto Hybond-N membranes (Amersham,
Amersham, U.K.). For blot hybridization, a full-length DMα probe (Kelly et al,
1991) and a PCR-amplificate corresponding to exons 3–6 of Ii were labeled
by random priming with [32P]dCTP (Amersham) (Feinberg and Vogelstein,
1983). After high-stringency washing, membranes were exposed for autoradio-
graphy.
Western blot analysis Cell lysates were prepared by solubilizing cells in cell
lysis buffer [50 mM HEPES pH 7.5, 150 mM NaCl, 1.5 mM MgCl2,
1 mM ethyleneglycol-bis(β-aminoethyl ether)-N,N,N’,N’-tetraacetic acid, 10%
glycerol, 1.5% NP-40] containing a mixture of protease inhibitors. After dilution
Figure 1. IFN-g-treated keratinocytes express the class II transcriptional
activators RFX5 and CIITA, as well as HLA-DR, HLA-DM, and Ii
genes (RT-PCR analysis). Normal human keratinocytes express constitutively
low amounts of RFX5 (470 bp), DMα (835 bp), and Ii-p33 (384 bp). Weak
signals corresponding to RFX5 and DMα are also detectable in NCTC cells
whereas A431 cells express constitutively low levels of all genes studied.
Treatment with IFN-γ (500 U per ml) for 24 h induces the transcripts for
CIITA (370 bp), DRα (645 bp), DMβ (300 bp), and Ii-p41 (560 bp). All
amplificates are identical to those present in Raji B cells.
with an equal volume of 2 3 SDS sample buffer (2% SDS final), lysates
corresponding to 5 3 105 cells (55–70 µg total protein content) were subjected
to SDS-polyacrylamide gel electrophoresis, and transferred to nitrocellulose
filter. Membranes were blocked, and then incubated using MoAb at appropriate
concentrations diluted in phosphate-buffered saline containing 3% bovine serum
albumin. Filters were developed with peroxidase-conjugated anti-mouse IgG
using the ECL immunodetection system (Amersham) followed by autoradio-
graphy. Quantitative assessment of Ii-p41 and Ii-p33 was determined by scanning
the autoradiographs with an imaging densitometer mod. GS-670 (Bio-Rad,
Hercules, CA) supported by the Molecular Analyst Image analysis software.
Flow cytometry analysis Expression of membrane HLA-DR was evaluated
by staining aliquots of 5 3 105 keratinocytes or Raji cells for 30 min on ice
with FITC-conjugated anti-HLA-DR, and analyzed with a FACScan equipped
with Cell Quest software (Becton Dickinson, Mountain View, CA). In control
samples, staining was performed using FITC-conjugated mouse IgG2a.
RESULTS AND DISCUSSION
Keratinocytes can express both class II transcriptional
activator genes and the molecules necessary for class II
maturation Various studies have demonstrated that following stimu-
lation with IFN-γ MHC class II molecules are induced on human
keratinocytes both in vivo and in vitro (Basham et al, 1984, 1985;
Aubo¨ck et al, 1986; Wikner et al, 1986), but no studies have investigated
whether induction of class II molecules is associated with the expression
of the accessory molecules, HLA-DM and Ii. Therefore, in the first
set of experiments the expression of these genes was analyzed on IFN-
γ-treated normal keratinocytes, and the epithelial cell lines NCTC and
A431. Raji B lymphoma cells were used as positive control. As shown
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Figure 2. IFN-g-stimulated, but not unstimulated, keratinocytes express
Ii-p33/p41 and HLA-DMα genes (northern blot analysis). Cultured
epithelial cells do not express constitutively appreciable amounts of Ii and DM
genes as evaluated by northern blot analysis. Transcripts become evident in
normal keratinocytes and A431 cells upon activation with IFN-γ (500 U per
ml, 24 h), although the levels are lower than those present in Raji cells. In
contrast, IFN-γ-treated NCTC cells do not show detectable amounts of
Ii-p41 mRNA.
in Fig 1, amplificates corresponding to α and β chains of HLA-DM
and to both transcriptional forms of Ii (p33 and p41) were detectable
in IFN-γ-activated keratinocytes, although low levels of transcripts
for HLA-DMα and Ii-p33 could also be revealed in unstimulated
keratinocytes. A similar pattern of expression of these genes was
observed in NCTC epithelial cells. In contrast, A431 keratinocyte-like
cells presented constitutive low levels of each transcript, that were all
upregulated following stimulation with IFN-γ. No signals relative to
the genes studied were detected in RNA from murine 3T3 fibroblasts
either treated or not treated with human IFN-γ (not shown). Although
RT-PCR analysis showed the presence of HLA-DMα and Ii-p33
mRNA in untreated keratinocytes, northern blot experiments did not
confirm these results (Fig 2), indicating that such mRNA are present
in unstimulated human keratinocytes at very low levels. Likewise,
A431 and NCTC cells expressed appreciable amounts of HLA-DMα
and Ii mRNA only after IFN-γ treatment.
The constitutive and IFN-γ-inducible transcription of MHC class
II, HLA-DM, and Ii genes is under the control of two major activators,
CIITA and RFX5 (Reith et al, 1995). Mutations of the genes encoding
these regulatory factors lead to a rare form of primary immunodeficiency
(bare lymphocyte syndrome) characterized by the absence of class II
antigens (Reith et al, 1995). Keratinocytes and NCTC cells constitu-
tively expressed RFX5 but not CIITA, whereas unstimulated A431
cells presented the mRNA for both transcription factors (Fig 1). Time-
course experiments with normal keratinocytes showed that stimulation
with IFN-γ led to expression of CIITA mRNA, which preceded the
de novo expression of HLA-DRα, HLA-DMβ, and Ii-p41 as well as
upregulation of Ii-p33 (Fig 3). These findings suggest that the
mechanisms regulating MHC class II transcription are partially distinct
from those regulating HLA-DM and Ii genes expression, and indicate
that the constitutive expression of RFX5 may be sufficient for inducing
the low levels of HLA-DMα and Ii-p33 mRNA present in unstimulated
keratinocytes. This hypothesis is in agreement with the observation
that in CIITA-deficient (–/–) mice the IFN-γ-inducible expression of
class II genes is impaired whereas the levels of Ii and H2-M gene
transcripts are substantially decreased but not absent, suggesting that
CIITA is a critical transactivator for the expression of MHC class II
genes but to a lesser degree for Ii and H2-M (Chang et al, 1996).
To determine the level of Ii and HLA-DM proteins in keratinocytes,
western blot analysis was performed. Consistent with the RNA data,
both p33/p35 forms of Ii were detected in IFN-γ-treated keratinocytes
or A431 cells, but not in unstimulated cells (Fig 4). Similar results
were obtained using the MoAb LN2 or PIN-1 that recognize the
COOH-terminus and the NH2-terminus of Ii, respectively. Interes-
Figure 3. RFX5 and CIITA precede HLA-DR, Ii, and HLA-DM gene
expression in IFN-γ-activated human keratinocytes. Upon treatment with
IFN-γ (500 U per ml), CIITA transcript becomes detectable after 3 h whereas
DRα, DMβ, and Ii-p41 mRNA appear after 6 h. RFX5 is constitutively
expressed as are DMα and Ii-p33 genes (RT-PCR analysis).
Figure 4. IFN-g-treated keratinocytes display Ii-p33/p41 and HLA-DM
proteins. Extracts prepared from Raji cells, keratinocytes, and A431 and
NCTC cells were evaluated by western blot analysis. Ii isoforms and DM are
present in Raji cells, and, upon IFN-γ-stimulation (500 U per ml, 48 h), also
become detectable in epithelial cells. NCTC cells express Ii-p33 but not Ii-
p41 or DM. Filters were probed with LN2 and PS/JG DMβ MoAb that
recognize Ii and DMβ subunit, respectively.
tingly enough, the Ii-p41/p33 ratio in keratinocytes was higher than
in Raji cells (0.25 vs 0.6 as measured by densitometry), which mainly
exhibited the Ii-p33/p35 forms. Indeed Ii-p41 appears to be less
represented in B cells compared with other antigen-presenting cells,
including Langerhans cells (Ka¨mpgen et al, 1991). In spite of the
apparent equivalent effect that p33 and p41 have on early events in
class II biosynthesis, the two forms of Ii differ in their functional effects
on antigen presentation to T cells. In fact, Ii-p41 has been shown to
enhance antigen presentation by inhibiting endosomal proteases, and
thus protect a subset of antigenic epitopes from excessive degradation
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Figure 5. IFN-g-activated keratinocytes express membrane SDS-stable
class II heterodimers. (a) Flow cytometry analysis: keratinocytes activated
with IFN-γ (500 U per ml, 48 h, shaded profiles), but not untreated keratinocytes
(–––––), express DR (L243 MoAb) on their surface; (· · · · ·) represent staining
with FITC-conjugated mouse IgG2a. Raji cells express higher amounts of
membrane DR than IFN-γ-activated keratinocytes. (b) Immunoblot analysis:
NP-40 lysates from IFN-γ-treated keratinocytes and Raji cells prepared in the
presence of 2% SDS contain DR protein dimer, which dissociates into the α
and β chains following boiling. The filters was stained with the TAL.1B5 and
DK22 MoAb, which recognize the α and the β monomers of DR, respectively.
Similar results were obtained using the MoAb DA6.147 (anti-DRα) and
HB10.A (anti-DRβ) together.
(Fineschi et al, 1996). The same expression pattern was observed for
HLA-DM, although protein levels were much lower in keratinocytes
and A431 cells compared with those present in Raji cells (Fig 4).
NCTC epithelial cells did not show IFN-γ inducible expression of
Ii-p41 and HLA-DM proteins but did display appreciable amounts of
Ii-p33/p35. HLA-DM catalyzes removal of CLIP from class II and its
replacement with antigenic peptides, and selects the peptides originating
stable class II-peptide complexes. In the absence of HLA-DM, class II
is unstable upon electrophoresis in SDS, and membrane class II is
exclusively associated with CLIP peptides (Sadegh-Nasseri and Ger-
main, 1991; Martin et al, 1996; Fung-Leung et al, 1996; Kropshofer
et al, 1997); however, the requirement for HLA-DM does not seem
to be absolute, as for certain class II alleles the efficient removal
of CLIP and subsequent peptide loading is HLA-DM independent
(Kropshofer et al, 1995; Stebbins et al, 1995).
MHC class IIF keratinocytes display SDS-stable HLA-DR heter-
odimers Class II molecules show remarkable resistance to SDS
denaturation at room temperature when their groove is occupied by
peptide. Mutant cell lines that are unable to present antigen in a
class II restricted fashion do not produce SDS-resistant α/β dimers,
producing instead class II molecules that dissociate into the constituent
monomers (Mellins et al, 1990). As shown in Fig 5, lysates from Raji
cells and IFN-γ-treated keratinocytes prepared in the presence of
standard concentration of SDS detergent contained HLA-DR class II
dimers that did not dissociate into the constituent α and β subunits,
indicating that class II1 keratinocytes generate mature MHC class II
peptide complexes. As expected, DRα chain monomers were also
present in unboiled lysates whereas DRβ monomers were not easily
detectable unless prolonged blot exposure was performed. Similar
results were observed with A431 cells. In contrast, lysates from IFN-
γ-activated NCTC cells did not show SDS-stable HLA-DR dimers
(not shown). Co-expression of Ii and HLA-DM molecules is required
for efficient formation of stable class II peptide complexes (Karlsson
et al, 1994). Therefore, the inability of NCTC cells to express SDS-
resistant HLA-DR dimers could be related to the very limited amounts
of HLA-DM molecules produced in response to IFN-γ. SDS-stable
class II dimers could also be detected in IFN-γ-treated keratinocytes
cultured in serum-free medium devoid of the bovine pituitary extract
and thus with very limited amounts of exogenous proteins (data not
shown), raising the possibility that nascent class II can be loaded
with peptides synthesized by keratinocyte themselves. The SDS-stable
phenotype is a marker of class II maturation, and is a necessary attribute
of functional class II peptide complexes; however, the presence of
SDS-stable dimers does not necessarily indicate loading with those
peptides that will be recognized by T cells (Stebbins et al, 1995;
Kropshofer et al, 1997).
Our study shows that, upon activation with IFN-γ, human ker-
atinocytes can express the genes for all the known molecules necessary
for the production of MHC class II peptide complexes, and display
peptide-loaded HLA-DR heterodimers on the cell surface.
Conflicting results have been reported on the ability of class II1
keratinocytes to present class II restricted protein antigens to T
lymphocytes. IFN-γ-treated human keratinocytes can serve as accessory
cells for T cell proliferation when stimuli such as PHA, anti-CD3 Ab,
or superantigens are employed (Nickoloff et al, 1993a). It was also
shown that Ia1 mouse keratinocytes were unable to present intact
proteins to specific CD41 T cell hybridomas, although they could
present immunogenic peptides, suggesting that mouse keratinocytes
cannot process exogenous native proteins (Gaspari and Katz, 1988). In
the human system, class II1 keratinocytes have been reported to present
Mycobacterium leprae antigens (hsp65) and induce proliferation of CD41
Th1 cells, indicating that human class II1 keratinocytes can process
and present some intact protein antigens (Mutis et al, 1993). Both
mouse and human class II1 keratinocytes induced proliferation of
alloreactive CD41 T cell lines (i.e., blasts), but not of resting T cells
(Nickoloff et al, 1986; Gaspari and Katz, 1988; Niederwieser et al,
1988). In addition, hapten or peptide presentation by murine or human
class II1 keratinocytes led to antigen-specific unresponsiveness rather
than proliferation of CD41 T cell clones (Gaspari et al, 1988; Bal et al,
1990). The inability of keratinocytes to express adequate levels of
costimulatory molecules such as CD80/CD86 (Nickoloff et al, 1993b;
Gaspari et al, 1993; Nickoloff and Turka, 1994) may explain their
failure to properly activate resting or naı¨ve T cells that are more
dependent on co-stimulation compared with activated or effector T
cells (Dubey et al, 1996). Therefore, it appears that keratinocytes can
express functional class II peptide complexes, with the fate of presenta-
tion depending on the co-stimulatory signal requirements of responder
T cells (Gaspari et al, 1993; Nickoloff and Turka, 1994).
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